Trade ImmuCell - ICCC CFD
Add to favourite- Summary
- Historical Data
Spread | 0.05 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.024124% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001901% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 3.63 |
Open | 3.64 |
1-Year Change | -19.82% |
Day's Range | 3.56 - 3.7 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Nov 21, 2024 | 3.63 | 0.04 | 1.11% | 3.59 | 3.74 | 3.43 |
Nov 20, 2024 | 3.51 | -0.03 | -0.85% | 3.54 | 3.58 | 3.39 |
Nov 19, 2024 | 3.59 | 0.20 | 5.90% | 3.39 | 3.61 | 3.39 |
Nov 18, 2024 | 3.52 | 0.00 | 0.00% | 3.52 | 3.56 | 3.52 |
Nov 15, 2024 | 3.55 | 0.16 | 4.72% | 3.39 | 3.61 | 3.39 |
Nov 14, 2024 | 3.52 | 0.15 | 4.45% | 3.37 | 3.52 | 3.37 |
Nov 13, 2024 | 3.52 | -0.17 | -4.61% | 3.69 | 3.69 | 3.49 |
Nov 12, 2024 | 3.52 | -0.07 | -1.95% | 3.59 | 3.59 | 3.50 |
Nov 11, 2024 | 3.52 | -0.07 | -1.95% | 3.59 | 3.64 | 3.51 |
Nov 8, 2024 | 3.53 | -0.03 | -0.84% | 3.56 | 3.56 | 3.53 |
Nov 7, 2024 | 3.52 | 0.03 | 0.86% | 3.49 | 3.53 | 3.49 |
Nov 6, 2024 | 3.51 | -0.05 | -1.40% | 3.56 | 3.59 | 3.51 |
Nov 5, 2024 | 3.55 | -0.03 | -0.84% | 3.58 | 3.64 | 3.51 |
Nov 4, 2024 | 3.55 | 0.00 | 0.00% | 3.55 | 3.56 | 3.52 |
Nov 1, 2024 | 3.57 | 0.02 | 0.56% | 3.55 | 3.61 | 3.54 |
Oct 31, 2024 | 3.55 | -0.01 | -0.28% | 3.56 | 3.61 | 3.55 |
Oct 30, 2024 | 3.64 | 0.08 | 2.25% | 3.56 | 3.64 | 3.55 |
Oct 29, 2024 | 3.56 | 0.00 | 0.00% | 3.56 | 3.56 | 3.56 |
Oct 28, 2024 | 3.56 | 0.00 | 0.00% | 3.56 | 3.56 | 3.56 |
Oct 25, 2024 | 3.56 | 0.01 | 0.28% | 3.55 | 3.60 | 3.50 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
ImmuCell Company profile
About ImmuCell Corporation
ImmuCell Corporation is an animal health company. The Company is engaged in development, acquisition, manufacture and sale of products that improve the health and productivity of dairy and beef cattle. It manufactures and markets the First Defense product line for the prevention of scours in newborn dairy and beef calves. It expanded this line into five different products with formulations targeting E. coli and coronavirus pathogens as well as E. coli, coronavirus and rotavirus pathogens. Its Tri-Shield First Defense product line extension is calf-level, passive antibody product providing immediate immunity against E. coli, coronavirus and rotavirus. These product line provides Immediate Immunity to newborn calves. The Company is engaged in development of Re-Tain, a Nisin treatment for subclinical mastitis in lactating dairy cows. Its products reduce the use of traditional antibiotics in food producing animals.
Financial summary
BRIEF: For the nine months ended 30 September 2021, ImmuCell Corporation revenues increased 19% to $13.8M. Net loss decreased 87% to $152K. Revenues reflect First Defense® product line segment increase of 44% to $9.5M, Other animal health segment increase of 83% to $186K, United States segment increase of 18% to $12.2M, Others segment increase of 28% to $1.6M.
Equity composition
Common Stock $.10 Par, 12/10, 8M auth., 3,261,148 issd., less 287,496 shs. in Treas. @ $635K. Insiders own 26.70%. PO 5/87, 966,000 Units (100 Common + 5 Warrants) @ $7/Unit by Stuart James. 7/90, 1-for-100 reverse stock split.
Industry: | Biotechnology & Medical Research (NEC) |
56 Evergreen Drive
PORTLAND
MAINE 04103
US
News
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
15:17, 18 November 2024Shiba Inu coin price prediction 2030: could Shiba Inu coin reach $1? Third party price target
Can Shiba Inu reinvent itself to become a worthy long-term investment?
08:36, 15 November 2024Trump trades charge as Bitcoin hits $US80,000
Bitcoin hits $80,000 amid expectations of fiscal stimulus, lower regulatory risks, and resilient US economy.
10:48, 13 November 2024Australian jobs data expected to point to solid labour market conditions
Australian labour market and wage data to reveal job growth resilience, shaping RBA rate cut expectations and impacting AUD amidst global economic shifts.
10:16, 13 November 2024FOMC cuts interest rates as expected and sticks to its line on future policy
The FOMC cut interest rates by 25 basis points at its November meeting, aligning with expectations. Wall Street hit record highs following the decision, with tech stocks leading the rally. Markets are pricing in a probable December cut amid resilient economic indicators.
13:33, 8 November 2024FOMC and BOE preview: further rate cuts expected
Both the Federal Reserve and the Bank of England are expected to cut rates further when they meet later this week.
14:14, 5 November 2024RBA meeting preview: No change to policy expected as inflation fight continues
The Reserve Bank of Australia is expected to keep its cash rate on hold at 4.35% when it announces its policy decision at 2.30PM on the 5th of November, 2024. Despite ongoing evidence of soft demand, upside risks to inflation are likely to remain the central bank’s primary concern.
13:35, 4 November 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com